X
DEAD

Serial Number

86983429

Owner

PRECIGEN, INC.

Attorney

Doyle Siever

Filing Date

Jul 16, 2014

Add to watchlist:

No watchlists yet
View on USPTO

X Trademark

Serial Number: 86983429 • Registration: 5375989

X is a trademark filed by PRECIGEN, INC. on July 16, 2014. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

PRECIGEN, INC. (55 trademarks)

1872 PRATT STREET, SUITE 1400
BLACKSBURG, VA 24060

Entity Type: 03

INTREXON CORPORATION (92 trademarks)

1872 PRATT DRIVE, SUITE 1400
BLACKSBURG, VA 24060

Entity Type: 03

Trademark Details

Filing Date

July 16, 2014

Registration Date

January 9, 2018

Published for Opposition

April 5, 2016

Cancellation Date

July 22, 2024

Goods & Services

Chemical preparations for medical and veterinary purposes, namely, chemical preparations for gene therapy, for treating genetic disorders, and for use as medical and veterinary diagnostic reagents for gene therapy analysis; biochemical preparations for medical and veterinary purposes, namely, biochemical preparations for gene therapy, for treating genetic disorders, and for use as medical and veterinary diagnostic reagents for gene therapy analysis; chemical inducers of gene expression in plants, mammals, fungi and bacteria for medical and veterinary applications; pharmaceutical and veterinary preparations which regulate the cellular functions of fungi, plants, bacteria and mammals and transgenic fungi, plants, bacteria and mammals; transgenic fungi and bacteria for medical and veterinary purposes

Chemicals, biochemicals and reagents for use in industry and science; chemicals for use in biochemical and chemical industry; chemicals for use in agriculture except fungicides, herbicides, insecticides and parasiticides; chemicals for use in biotechnological product development; chemicals for use in biotechnological manufacturing processes; chemical preparations for scientific purposes; chemical reagents for non-medical purposes; chemicals, biochemicals and reagents, namely, proteins for regulating, modifying or restricting gene expression, ligands, genetic vectors, genetic hosts, genetic biochemicals, genetic bioengineering reagents and protein receptors for use in regulating cellular functions in transgenic plants, fungi and animals, and in cells of plants, fungi and animals; kits consisting primarily of proteins for regulating, modifying or restricting gene expression; research reagents for pharmaceutical discovery or disease research, drug discovery or drug development; chemical inducers of gene expression in plants, mammals, fungi and bacteria for industrial and agricultural applications; chemicals and chemical reagents, namely, cells of transgenic animals, transgenic plants and transgenic fungi, and cells of animals, plants or fungi for use in medical, pharmaceutical and veterinary laboratory research

Development of new technology for others in the field of medicine, genetics, therapeutics, biotechnology, and energy, fuels, biofuels, and agriculture; development of products being genetic approaches effectors to regulate, modulate, and characterize disease states; development of tools in the nature of software and biotechnological processes to regulate, modulate, and characterize cell function or disease states; research and development services for others in the fields of biotechnology and genetics, namely, genetically engineering DNA, biological organisms, cells, viruses, pathogens, and special purpose cells for scientific, research, medical and laboratory use; Scientific research and product development services for others in the chemical, biochemical, pharmaceutical, biotechnology, biosensors, bioelectronics, medical, animal therapeutics, energy, fuels, biofuels, and agriculture fields; gene therapy services for others for product development and scientific research purposes, namely, genetically engineering DNA, biological organisms, cells, viruses, pathogens, and special purpose cells for scientific, research, medical and laboratory use; Providing temporary use of non-downloadable computer software for storing, managing, modifying, sharing, and synthesizing data for use in connection with research and development services in the fields of chemical, biochemical, synthetic biology, energy, agriculture, genetics, environment, animal therapeutics, medicine, gene therapy, and biotechnology; Providing temporary use of non-downloadable computer software for creating databases and for web-based research for use in connection with research and development services in the fields of chemical, biochemical, synthetic biology, energy, agriculture, genetics, environment, animal therapeutics, medicine, gene therapy, and biotechnology; Providing temporary use of non-downloadable computer software for use as a web-based custom order and purchasing system for use in connection with research and development services in the fields of chemical, biochemical, synthetic biology, energy, agriculture, genetics, environment, animal therapeutics, medicine, gene therapy, and biotechnology; Providing temporary use of non-downloadable computer software for storing, managing, modifying, sharing, and synthesizing data for use in connection with research and development of new technology for others in the fields of chemical, biochemical, synthetic biology, energy, agriculture, genetics, environment, animal therapeutics, medicine, gene therapy, and biotechnology; Providing temporary use of non-downloadable computer software for creating databases and for web-based research for use in connection with research and development of new technology for others in the fields of chemical, biochemical, synthetic biology, energy, agriculture, genetics, environment, animal therapeutics, medicine, gene therapy, and biotechnology; Providing temporary use of non-downloadable computer software for use as a web-based custom order and purchasing system for use in connection with research and development of new technology for others in the fields of chemical, biochemical, synthetic biology, energy, agriculture, genetics, environment, animal therapeutics, medicine, gene therapy, and biotechnology; Providing temporary use of non-downloadable computer software for generating and tracking orders in the fields of chemical, biochemical, synthetic biology, energy, agriculture, genetics, environment, animal therapeutics, medicine, gene therapy, and biotechnology; Computer services, namely, providing an interactive web site featuring technology that allows users to view, store, and manage data for use in connection with research and development of new technology for others in the fields of chemical, biochemical, synthetic biology, energy, agriculture, genetics, environment, animal therapeutics, medicine, gene therapy, and biotechnology

Filing History

CANCELLED SEC. 8 (6-YR)
Jul 22, 2024 C8..
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Feb 7, 2024 ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Feb 7, 2024 ASCK
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jan 9, 2023 REM1
REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Jun 9, 2020 CORV
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 16, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 16, 2020 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Apr 16, 2020 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 16, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 16, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 16, 2020 COAR
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Apr 8, 2020 ASGN
REGISTERED-PRINCIPAL REGISTER
Jan 9, 2018 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Dec 8, 2017 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Dec 7, 2017 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Dec 5, 2017 SUPC
DIVISIONAL PROCESSING COMPLETE
Dec 5, 2017 DPCC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 4, 2017 AITU
USE AMENDMENT FILED
Nov 28, 2017 IUAF
DIVISIONAL REQUEST RECEIVED
Nov 28, 2017 DRRR
TEAS REQUEST TO DIVIDE RECEIVED
Nov 28, 2017 ERTD
TEAS STATEMENT OF USE RECEIVED
Nov 28, 2017 EISU
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 26, 2017 TCCA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 2, 2017 EXRA
SOU EXTENSION 2 GRANTED
May 31, 2017 EX2G
SOU EXTENSION 2 FILED
May 31, 2017 EXT2
SOU TEAS EXTENSION RECEIVED
May 31, 2017 EEXT
PETITION TO DIRECTOR DENIED
Mar 30, 2017 PCDE
ASSIGNED TO PETITION STAFF
Feb 1, 2017 APET
ASSIGNED TO PETITION STAFF
Jan 27, 2017 APET
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 25, 2016 EXRA
SOU EXTENSION 1 GRANTED
Nov 23, 2016 EX1G
SOU EXTENSION 1 FILED
Nov 23, 2016 EXT1
SOU TEAS EXTENSION RECEIVED
Nov 23, 2016 EEXT
TEAS PETITION TO DIRECTOR RECEIVED
Nov 16, 2016 TPDR
PETITION TO DIRECTOR DENIED
Sep 16, 2016 PCDE
ASSIGNED TO PETITION STAFF
Sep 14, 2016 APET
TEAS PETITION TO DIRECTOR RECEIVED
Jul 22, 2016 TPDR
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 31, 2016 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 5, 2016 NPUB
PUBLISHED FOR OPPOSITION
Apr 5, 2016 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 16, 2016 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 2, 2016 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 2, 2016 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 13, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 12, 2016 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Feb 12, 2016 ERSI
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Oct 5, 2015 RCSC
ASSIGNED TO LIE
Sep 29, 2015 ALIE
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Mar 23, 2015 GNS3
LETTER OF SUSPENSION E-MAILED
Mar 23, 2015 GNSL
SUSPENSION LETTER WRITTEN
Mar 23, 2015 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 18, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 18, 2015 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 18, 2015 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 18, 2014 GNRN
NON-FINAL ACTION E-MAILED
Sep 18, 2014 GNRT
NON-FINAL ACTION WRITTEN
Sep 18, 2014 CNRT
ASSIGNED TO EXAMINER
Sep 12, 2014 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 22, 2014 NWOS
NEW APPLICATION ENTERED
Jul 19, 2014 NWAP